Cargando…
Genomic imbalance in endometrial hyperplasia and cancer
Autores principales: | Bednarek, Michal, Constantinou, Maria, Kepczynski, Lukasz, Kassassir, Agata Shiar, Sobczuk, Anna, Wieszczycka, Maria, Suzin, Jacek, Kaluzewski, Bogdan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565641/ http://dx.doi.org/10.1186/1897-4287-13-S1-A16 |
Ejemplares similares
-
The prevalence of CHEK2 and CYP1B1 mutations/polymorphisms in urinary bladder cancer
por: Banaszkiewicz, Monika, et al.
Publicado: (2012) -
Artificial neural network in predicting bladder cancer recurrence
por: Borkowska, Edyta, et al.
Publicado: (2012) -
Concomitance of oncogenic HPV types, CHEK2 gene mutations, and CYP1B1 gene polymorphism as an increased risk factor for malignancy
por: Banaszkiewicz, Monika, et al.
Publicado: (2013) -
Assessment of endometrial receptor systems for PPPM approach for endometrial hyperplasia in reproductive age women
por: Goncharenko, Vadym M, et al.
Publicado: (2014) -
Personalized treatment strategy for atypical endometrial hyperplasia with regards to age, comorbidities and endometrial receptor status
por: Goncharenko, Vadym M, et al.
Publicado: (2014)